BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cohen RS, Karlin P, Yushak M, Mancini D, Maurer MS. The effect of erythropoietin on exercise capacity, left ventricular remodeling, pressure-volume relationships, and quality of life in older patients with anemia and heart failure with preserved ejection fraction. Congest Heart Fail 2010;16:96-103. [PMID: 20557328 DOI: 10.1111/j.1751-7133.2009.00135.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Ennezat PV, Le Jemtel TH, Logeart D, Maréchaux S. [Heart failure with preserved ejection fraction: a systemic disorder?]. Rev Med Interne 2012;33:370-80. [PMID: 22424669 DOI: 10.1016/j.revmed.2012.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
2 Altincatal A, Macarthur RB, Teruya S, Helmke S, Maurer MS. A dosing algorithm for erythropoietin alpha in older adults with heart failure and a preserved ejection fraction. Cardiovasc Ther 2013;31:92-9. [PMID: 21884028 DOI: 10.1111/j.1755-5922.2011.00295.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Ather S, Chan W, Bozkurt B, Aguilar D, Ramasubbu K, Zachariah AA, Wehrens XH, Deswal A. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol 2012;59:998-1005. [PMID: 22402071 DOI: 10.1016/j.jacc.2011.11.040] [Cited by in Crossref: 421] [Cited by in F6Publishing: 376] [Article Influence: 42.1] [Reference Citation Analysis]
4 Gaddam KK, Jarreau T, Ventura H. Developments in Heart Failure 2010: developments in heart failure 2010. Congestive Heart Failure 2011;17:92-100. [DOI: 10.1111/j.1751-7133.2011.00219.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Wright S, Pearce B, Snowden C, Anderson H, Wallis J. Cardiopulmonary exercise testing before and after blood transfusion: a prospective clinical study. British Journal of Anaesthesia 2014;113:91-6. [DOI: 10.1093/bja/aeu050] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
6 Green P, Babu BA, Teruya S, Helmke S, Prince M, Maurer MS. Impact of epoetin alfa on left ventricular structure, function, and pressure volume relations as assessed by cardiac magnetic resonance: the heart failure preserved ejection fraction (HFPEF) anemia trial. Congest Heart Fail 2013;19:172-9. [PMID: 23517485 DOI: 10.1111/chf.12027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Nijholt KT, Meems LMG, Ruifrok WPT, Maass AH, Yurista SR, Pavez-Giani MG, Mahmoud B, Wolters AHG, van Veldhuisen DJ, van Gilst WH, Silljé HHW, de Boer RA, Westenbrink BD. The erythropoietin receptor expressed in skeletal muscle is essential for mitochondrial biogenesis and physiological exercise. Pflugers Arch 2021;473:1301-13. [PMID: 34142210 DOI: 10.1007/s00424-021-02577-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Guo L, Wang AH, Sun YL, Lv L, Xu CE. Serum erythropoietin level predicts the prognosis of chronic heart failure with or without anemia. Exp Ther Med 2013;6:1327-31. [PMID: 24223667 DOI: 10.3892/etm.2013.1307] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
9 Montero D, Lundby C, Ruschitzka F, Flammer AJ. True Anemia―Red Blood Cell Volume Deficit―in Heart Failure: A Systematic Review. Circ: Heart Failure 2017;10. [DOI: 10.1161/circheartfailure.116.003610] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
10 Mohammed SF, Borlaug BA, Roger VL, Mirzoyev SA, Rodeheffer RJ, Chirinos JA, Redfield MM. Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail 2012;5:710-9. [PMID: 23076838 DOI: 10.1161/CIRCHEARTFAILURE.112.968594] [Cited by in Crossref: 148] [Cited by in F6Publishing: 63] [Article Influence: 14.8] [Reference Citation Analysis]
11 Borovka M, Teruya S, Alvarez J, Helmke S, Maurer MS. Differences in blood volume components between hyporesponders and responders to erythropoietin alfa: the heart failure with preserved ejection fraction (HFPEF) anemia trial. J Card Fail 2013;19:685-91. [PMID: 24125107 DOI: 10.1016/j.cardfail.2013.08.508] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
12 Maurer MS, Teruya S, Chakraborty B, Helmke S, Mancini D. Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacy. Circ Heart Fail 2013;6:254-63. [PMID: 23258574 DOI: 10.1161/CIRCHEARTFAILURE.112.969717] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]